Destination Wealth Management Novartis Ag Transaction History

Destination Wealth Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$85.54 - $94.26 $45,421 - $50,052	-531 Closed	0 $0
Q2 2019 Jul 19, 2019	SELL	$75.4 - $92.8 $27,898 - $34,336	-370 Reduced 41.07%	531 $48,000
Q1 2019 May 01, 2019	SELL	$75.32 - $86.15 $6,477 - $7,408	-86 Reduced 8.71%	901 $87,000
Q4 2018 Feb 05, 2019	BUY	$73.66 - $82.02 $19,814 - $22,063	269 Added 37.47%	987 $85,000
Q3 2018 Nov 07, 2018	BUY	$66.94 - $77.43 $7,898 - $9,136	118 Added 19.67%	718 $62,000
Q2 2018 Jul 31, 2018	SELL	$64.91 - $73.36 $778 - $880	-12 Reduced 1.96%	600 $45,000
Q1 2018 Apr 05, 2018	BUY	$70.39 - $84.15 $43,078 - $51,499	612 New	612 $49,000

1,462

132M

1.33M

1.54M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $227B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Destination Wealth Management with notifications on news.